Fig. 1: Differences between groups in symptom severity and hormonal levels. | Neuropsychopharmacology

Fig. 1: Differences between groups in symptom severity and hormonal levels.

From: Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator

Fig. 1

Descriptive panel showing the effect of SPRM treatment in comparison with placebo, according to the Daily Record of Severity of Problems (DRSP) total score (d = 1.09) (A), the four subscales, depression, anxiety, affective lability, and irritability (B), and hormone levels, indicated by the mean concentrations of estradiol, progesterone, and testosterone (C). Error bars indicate 95% confidence intervals. *: p ≤ 0.05; ¤: p ≤ 0.1.

Back to article page